<SEC-DOCUMENT>0001712543-25-000039.txt : 20250520
<SEC-HEADER>0001712543-25-000039.hdr.sgml : 20250520
<ACCEPTANCE-DATETIME>20250520171814
ACCESSION NUMBER:		0001712543-25-000039
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250520
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250520
DATE AS OF CHANGE:		20250520

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EQUUS TOTAL RETURN, INC.
		CENTRAL INDEX KEY:			0000878932
		ORGANIZATION NAME:           	
		EIN:				760345915
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	814-00098
		FILM NUMBER:		25969973

	BUSINESS ADDRESS:	
		STREET 1:		700 LOUISIANA STREET
		STREET 2:		48TH FLOOR
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002
		BUSINESS PHONE:		7135290900

	MAIL ADDRESS:	
		STREET 1:		700 LOUISIANA STREET
		STREET 2:		48TH FLOOR
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EQUUS II INC
		DATE OF NAME CHANGE:	19970422
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k_equus05202025.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 20pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B>___________________________________________</B></P>

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event reported): May
15, 2025</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EQUUS TOTAL RETURN, INC.</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 11pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;&nbsp;&nbsp;<B>814-00098</B></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 11pt"><B>76-0345915</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">(State or Other Jurisdiction</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">(Commission File</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">(IRS Employer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">Of Incorporation)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">Number)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">Identification No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>700 Louisiana Street, 41<SUP>st</SUP> Floor Houston,
    Texas</B></P></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>77002</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">(Address of Principal Executive Offices)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 8pt">(Zip Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Registrant&rsquo;s telephone number, including area
code: (713) 529-0900</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former Name or Former Address, if Changed Since Last
Report)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form 8-k filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 6pt 0 0; background-color: white">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &sect;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &sect;240.12b-2). <FONT STYLE="font-family: MS Mincho">&#9744;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: MS Mincho">&#9744;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 3.01</B></TD><TD><B>Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.</B></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On May 15, 2025, Equus Total Return, Inc. (the &ldquo;Company&rdquo;)
was notified by the New York Stock Exchange (the &ldquo;NYSE&rdquo;) that it is not in compliance with Section 802.01C of the NYSE Listed
Company Manual because the average closing price of the Company&rsquo;s Common Stock (the &ldquo;Common Stock&rdquo;) was less than $1.00
over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company&rsquo;s Common Stock from
the NYSE.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company plans to notify the NYSE by May 25, 2025
that it intends to cure the average closing stock price deficiency and to return to compliance with the NYSE's continued listing standards.
The Company can regain compliance at any time within the six-month period following receipt of the NYSE's notice if on the last trading
day of any calendar month during the cure period, the Company has (i) a closing share price of at least $1.00 and (ii) an average closing
share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company intends to consider available alternatives
to cure the stock price non-compliance including, but not limited to, a reverse stock split, authorization for which has been proposed
in connection with the Company&rsquo;s upcoming annual meeting of stockholders scheduled for June 26, 2025. Under the NYSE&rsquo;s rules,
if the Company determines that it will cure the stock price deficiency by taking an action that will require stockholder approval at its
next annual meeting of stockholders, the price condition will be deemed cured if the price promptly exceeds $1.00 per share, and the price
remains above that level for at least the following 30 trading days.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Company&rsquo;s Common Stock will continue to be
listed and trade on the NYSE during this period, subject to the Company&rsquo;s ongoing compliance with the NYSE's other continued listing
standards. Furthermore, the notice is not anticipated to impact the ongoing business operations of the Company or its reporting requirements
with the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -1in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 7.01</B></TD><TD><B>Regulation FD Disclosure</B>.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As required by Section 802.01C of the NYSE Listed Company
Manual, the Company issued a press release on May 20, 2025, announcing that it had received the notice of noncompliance with the NYSE&rsquo;s
continued listing standard. A copy of the press release is furnished herewith as Exhibit 99.1.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The information in this Item 7.01, including the information
contained in Exhibit 99.1 of this Current Report on Form 8-K, is being furnished herewith and shall not be deemed &ldquo;filed&rdquo;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), or otherwise subject to
the liabilities under that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as
amended (the &ldquo;Securities Act&rdquo;), or the Exchange Act, regardless of any general incorporation language in such filing.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits.</B></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>(d) Exhibits.</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><A HREF="ex991_pressrelease.htm">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release dated May 20, 2025.</A></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>SIGNATURES</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; padding-right: -45pt; padding-left: 5.4pt"></TD>
    <TD STYLE="width: 50%; padding-right: -45pt; padding-left: 5.4pt"><FONT STYLE="font-size: 11pt">Equus Total Return, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -45pt; padding-left: 5.4pt"><FONT STYLE="font-size: 11pt">Date:&nbsp;&nbsp;May 20,
    2025&#9;</FONT></TD>
    <TD STYLE="padding-right: -45pt; padding-left: 5.4pt"><FONT STYLE="font-size: 11pt">By:&nbsp;&nbsp;<U>/s/ Kenneth I. Denos&#9;</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -45pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: -45pt; padding-left: 5.4pt"><FONT STYLE="font-size: 11pt">Name:&#9;Kenneth I. Denos</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -45pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: -45pt; padding-left: 5.4pt"><FONT STYLE="font-size: 11pt">Title: &#9;Secretary</FONT></TD></TR></TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991_pressrelease.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 380pt"><FONT STYLE="font-size: 9pt"><A HREF="f8k_equus05202025.htm">EXHIBIT 99.1</A></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="image_001.jpg" ALT="Logo, company name&#10;&#10;Description automatically generated" STYLE="height: 79px; width: 131px"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Contact:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Equus Total Return, Inc.<BR>
1-888-323-4533</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><BR>
<BR>
</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EQUUS RECEIVES NOTICE OF NON-COMPLIANCE WITH</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NEW YORK STOCK EXCHANGE SHARE PRICE RULE</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>Company Intends to Regain Compliance with NYSE Rule</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>Notice Has No Immediate Impact on the Listing or
Trading of Equus Common Stock</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; color: navy">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>HOUSTON, TX &ndash; May 20, 2025 &ndash; Equus
Total Return, Inc. (NYSE: EQS) </B>(&ldquo;Equus&rdquo; or the &ldquo;Company&rdquo;) announced today that it was notified by the New
York Stock Exchange (the &ldquo;NYSE&rdquo;) on May 15, 2025, that it is not in compliance with Section 802.01C of the NYSE Listed Company
Manual because the average closing price of the Company&rsquo;s Common Stock (&ldquo;Common Stock&rdquo;) was less than $1.00 over a consecutive
30 trading-day period, which is the minimum average closing price required to maintain continued listing on the NYSE. The notice is a
notice of deficiency, not delisting, and does not currently affect the listing or trading of the Company&rsquo;s Common Stock on the NYSE.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company plans to notify the NYSE by May 25, 2025
that it intends to cure the average closing stock price deficiency and to return to compliance with the NYSE's continued listing standards.
The Company can regain compliance at any time within the six-month period following receipt of the NYSE's notice if on the last trading
day of any calendar month during the cure period, the Company has (i) a closing share price of at least $1.00 and (ii) an average closing
share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company intends to consider available alternatives
to cure the stock price noncompliance including, but not limited to, a reverse stock split, authorization for which has been proposed
in connection with the Company&rsquo;s upcoming annual meeting of stockholders scheduled for June 26, 2025. Under the NYSE&rsquo;s rules,
if the Company determines that it will cure the stock price deficiency by taking an action that will require stockholder approval at its
next annual meeting of stockholders, the price condition will be deemed cured if the price promptly exceeds $1.00 per share, and the price
remains above that level for at least the following 30 trading days.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&rsquo;s Common Stock will continue to
be listed and trade on the NYSE during this period, subject to the Company&rsquo;s ongoing compliance with the NYSE's other continued
listing standards. Furthermore, the notice is not anticipated to impact the ongoing business operations of the Company or its reporting
requirements with the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>About Equus<BR>
<BR>
</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a business development company that
trades as a closed-end fund on the New York Stock Exchange under the symbol &quot;EQS&quot;. Additional information on the Company may
be obtained from the Company&rsquo;s website at <I>www.equuscap.com</I>.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 8.5pt/11.25pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt; text-align: justify"><FONT STYLE="font-size: 7pt">This
press release may contain certain forward-looking statements regarding future circumstances. These forward-looking statements are based
upon the Company&rsquo;s current expectations and assumptions and are subject to various risks and uncertainties that could cause actual
results to differ materially from those contemplated in such forward-looking statements including, in particular, the performance of
the Company, including our ability to achieve our expected financial and business objectives, and the other risks and uncertainties described
in the Company&rsquo;s filings with the SEC. Actual results, events, and performance may differ. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as to the date hereof. Except as required by law, the Company undertakes
no obligation to release publicly any revisions to these forward-looking statements that may be made to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated events. The inclusion of any statement in this release does not constitute
an admission by the Company or any other person that the events or circumstances described in such statements are material.</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !/ (,# 2(  A$! Q$!_\0
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)HHH **** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
